Study to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK2646264
Clinical trial NCT02424799 · COMPLETED
Trial details
- NCT number
- NCT02424799
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-17
- Primary completion
- 2017-11-10
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.